Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Alleima AB is a Sweden-based global developer, manufacturer, and supplier of high value-added products in advanced stainless steels, special alloys, and industrial heating solutions. Headquartered in Sandviken, the company specializes in materials technology that enhances customer products and processes, making them safer, more sustainable, and efficient, particularly in supporting the energy transition and improved quality of life. Its offerings include seamless stainless tubes, precision strip steel, ultra-fine wire and components for medical devices, coated strip for hydrogen applications, and electric heating technologies under the Kanthal brand. Alleima serves diverse industries such as energy, medical, nuclear power, oil and gas, automotive, and aerospace, with operations spanning 80 countries and sales distributed across regions including the USA, Sweden, China, and others. Originating from Sandvik Materials Technology and spun off as an independent entity in 2022, Alleima employs approximately 6,800 people and maintains a portfolio of over 900 active alloys, underscoring its role as a leader in metallic rolling and drawing products within the iron and steel sector.
kr 92.29
kr 1.46 (-1.56%)
Live · 04:12 PM · Twelve Data
Operating margin is thin at 5.36%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 5.4% YoY. Margins deteriorated 2.0pp alongside, both lines moving the wrong way.
At 41x earnings, the current multiple leaves limited room for execution misses or growth deceleration. ROIC dropped from 6.78% to 4.05%, capital efficiency is deteriorating.
40.7x earnings, 31.6x FCF. The market is pricing in years of above-average growth. If that thesis breaks, downside from multiple compression alone could be 30%+. This is a stock where you're paying for the future, not the present.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
kr 18.06B
▼ -5.4% YoY
Net Income (TTM)
kr 567M
▼ -45.0% YoY
Op. Margin
4.85%
▼ -2.0pp YoY
ROIC
4.05%
▼ -2.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
kr 732M
▼ -7.5% YoY
Op. Cash Flow (TTM)
kr 1.85B
▲ +19.7% YoY
Net Debt
-kr 1.45B
Net Cash Position
Cash & Equiv.
kr 1.89B
3Y CAGR: +0.4%
3Y CAGR: +356.8%
Continue Research
At a P/E of 40.7 and a price-to-free-cash-flow of 31.6, Alleima AB (ALLEI.XSTO) trades above a two-stage DCF intrinsic value of about SEK 57.02 per share, so at SEK 92.29 the stock looks overvalued (38.2% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Alleima AB scores 43/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 2.5%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about SEK 57.02 per share for ALLEI.XSTO, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around SEK 42.76. At today's SEK 92.29, that puts the stock about 38.2% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Alleima AB scores 43 out of 100 on Intrinsiqq's quality score, passing 3 of 8 checks, which makes it a mixed business on these measures. Recent fundamentals include a 4.8% operating margin and a 4.1% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full check-by-check breakdown is on the quality scorecard.
Yes, Alleima AB pays a regular dividend of about SEK 2.29 per share per year (typically in quarterly installments), a yield of roughly 2.5% at the current price. That is a payout ratio of about 101.4% of earnings, so the dividend is stretched at this level. Alleima AB has grown the dividend at roughly 476.6% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For ALLEI.XSTO's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. ALLEI.XSTO currently trades above its estimated intrinsic value and scores 43/100 on quality (mixed). It also yields about 2.5%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.